50" per 1 cm3 of the vaccine.;EFFECT: vaccine is better than common vaccines in the spectrum of specific protection and effectiveness for tolerant group of animals, duration of intense immunity, harmlessness for incalvers and newborn calves, stability of biological properties throughout 18 months (follow-up period).;3 cl, 12 tbl, 6 ex"/> INACTIVATED COMBINED VACCINE AGAINST CATTLE INFECTIOUS RHINOTRACHEITIS, PARAINFLUENZA-3, VIRUS DIARRHOEA, RESPIRATORY SYNCYTIAL ROTA- AND CORONAVIRAL DISEASE
首页> 外国专利> INACTIVATED COMBINED VACCINE AGAINST CATTLE INFECTIOUS RHINOTRACHEITIS, PARAINFLUENZA-3, VIRUS DIARRHOEA, RESPIRATORY SYNCYTIAL ROTA- AND CORONAVIRAL DISEASE

INACTIVATED COMBINED VACCINE AGAINST CATTLE INFECTIOUS RHINOTRACHEITIS, PARAINFLUENZA-3, VIRUS DIARRHOEA, RESPIRATORY SYNCYTIAL ROTA- AND CORONAVIRAL DISEASE

机译:牛传染性鼻气管炎,PARAINFLUENZA-3,病毒性腹泻,呼吸道合胞性旋转和冠状病毒病的灭活联合疫苗

摘要

FIELD: medicine.;SUBSTANCE: invention refers to biotechnology. The vaccine contains an active substance and target additives. The active substance is presented with mixed inactivated suspension of cattle infectious rhinotracheitis virus strain, SVC (State Virus Collection) No. 2333, Herpesviridae family, Alphaherpesviridae subfamily; inactivated suspension of cattle parainfluenza-3 virus strain, SVC No. 2334, Paramixoviridae subfamily, Paramixovirus genus; inactivated suspension of cattle diarrhoea virus strain, SVC No. 2336, Flaviviridae family, Pestivims genus; inactivated suspension of cattle respiratory syncytial disease, SVC No. 2335, Pneumoviridae subfamily, Pneumovirus genus; inactivated suspension of cattle rotavirus strain, SVC No. 2337, Reoviridae family, Rotavirus genus, inactivated suspension of cattle coronavirus strain, SVC No. 2338, Coronaviridae family, Coronavirus genus, with activity of each strain not less than 106.5 "ТЦД50" per 1 cm3 of the vaccine.;EFFECT: vaccine is better than common vaccines in the spectrum of specific protection and effectiveness for tolerant group of animals, duration of intense immunity, harmlessness for incalvers and newborn calves, stability of biological properties throughout 18 months (follow-up period).;3 cl, 12 tbl, 6 ex
机译:领域:医学。;物质:发明涉及生物技术。疫苗包含活性物质和目标添加剂。活性物质与牛传染性鼻气管炎病毒株,SVC(国家病毒库)2333号,疱疹病毒科,疱疹病毒科亚科的混合灭活悬浮液一起提供。牛副流感3病毒株SVC No. 2334,副混合病毒科亚科,副混合病毒属的灭活悬浮液;牛腹泻病毒株,SVC 2336,黄病毒科,Pestivims属的灭活悬浮液;牛呼吸道合胞病的灭活悬浮液,SVC 2335号,肺炎科,肺炎病毒属;牛轮状病毒株,呼肠孤病毒科,轮状病毒属的灭活悬液,牛冠状病毒株,2338,冠状病毒科,冠状病毒属的灭活悬液,每株的活性均不低于10 6.5 < / Sup>每1 cm 3 疫苗中的“ТЦД 50 ”。效果:该疫苗在对耐受性较弱的人群的特异性保护和有效性方面优于普通疫苗动物,强烈的免疫力持续时间,对犊牛和新生小牛无害,在18个月内(随访期)的生物学特性稳定。; 3 cl,12 tbl,6 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号